Systematic review finds limited evidence for medicinal cannabis effectiveness in mental health conditions
Consensus Summary
A large-scale systematic review published in The Lancet Psychiatry found no evidence that medicinal cannabis is effective for treating anxiety, depression, PTSD, or other common mental health conditions despite its widespread use. Conducted by researchers from Australian and UK universities, the study analyzed 54 randomized controlled trials involving 2,477 participants and concluded that routine prescribing for mental health disorders is not justified. While some low-quality evidence suggested potential benefits for Tourette’s syndrome, insomnia, and autism traits, the overall consensus was that the evidence base remains insufficient. The review was prompted by the global legalization of medicinal cannabis, with Australia seeing prescriptions skyrocket from fewer than 20,000 in 2020 to nearly 1 million in the last financial year. Critics, including the Cannabis Industry Council, argue the findings overlook real-world patient benefits, while experts like Sir Robin Murray warn that cannabis clinics may mislead patients by exaggerating therapeutic claims. The study also highlighted gaps in research, particularly the lack of high-quality trials distinguishing between THC and CBD products, and the slow pace of clinical research amid rapid prescribing growth.
✓ Verified by 2+ sources
Key details reported by multiple sources:
- Medicinal cannabis prescriptions in Australia increased from fewer than 20,000 in 2020 to nearly 1 million in the last financial year (SMH, Guardian)
- The University of Sydney-led systematic review analyzed 54 randomized controlled trials involving 2,477 participants (Guardian) and found no evidence medicinal cannabis is effective for treating anxiety, depression, or PTSD (SMH, Guardian)
- Researchers found some low-quality evidence that medicinal cannabis may reduce tic severity in Tourette’s syndrome, increase sleep time for insomniacs, and help manage autism traits (SMH, Guardian)
- The review was published in *The Lancet Psychiatry* (Guardian) and involved researchers from the University of Sydney, Brisbane, Melbourne, and Bath (Guardian)
- Legal medicinal cannabis sales in Australia have tripled in four years (SMH)
- The review concluded there was 'very little evidence for its efficacy' in treating common mental health conditions (Guardian)
- The study was prompted by the legalization of medicinal cannabis for mental health and substance use disorders in countries including the US, UK, Australia, and Canada (Guardian)
Points of Difference
Details reported by only one source:
- Prescriptions for medicinal cannabis for psychiatric and mental health conditions include over 250,000 for anxiety, 19,000 for PTSD, and 17,641 for depression (federal government data)
- Daniel Yacoel, 33, from Darwin, was prescribed medicinal cannabis for anxiety and depression after a relationship breakdown and consumed up to 60 grams monthly before quitting due to cost and dependency concerns
- Dr Jack Wilson (University of Sydney’s Matilda Centre) noted that while anecdotal reports suggest effectiveness, there have been very few randomized controlled trials assessing safety and effectiveness
- Iain McGregor (University of Sydney) highlighted that the review did not distinguish between THC-dominant and CBD-dominant cannabis products
- The Cannabis Council (representing producers, prescribers, and pharmacists) supported high-quality research but did not directly address industry funding for clinical trials
- Three clinical trials are underway in Australia to test medicinal cannabis for mental health conditions, including studies involving children with autism and a study testing CBD for anxiety in young people (Orygen)
- The review included evidence from clinics showing mental illnesses like anxiety and depression are the main reasons patients cite for using medicinal cannabis, followed by chronic pain
- Sir Robin Murray (King’s College London) criticized UK cannabis clinics as 'drug dealers for the middle class' and stated therapeutic benefits are 'extremely limited' with common side effects
- Mike Morgan-Giles (Cannabis Industry Council) claimed real-world evidence from T21 shows medicinal cannabis reduces symptoms for anxiety and PTSD, contradicting the review’s findings
- The Advisory Council on the Misuse of Drugs in the UK is conducting a review of the 2018 legalization of cannabis-based products, including unintended consequences
- Prof Owen Bowden-Jones (Royal College of Psychiatrists) stated the review 'gives the clearest indication yet that the benefits of cannabis as a medicine may have been overstated for many conditions'
Contradictions
Conflicting information between sources:
- The Guardian reports the review found no evidence for medicinal cannabis effectiveness in treating anxiety, depression, or PTSD, but the Cannabis Industry Council claims real-world evidence shows it reduces symptoms for these conditions
- The Guardian cites Sir Robin Murray calling UK cannabis clinics 'drug dealers for the middle class,' while the Cannabis Industry Council insists patients with psychiatric conditions need access to the treatment
- The Guardian states there was no evidence cannabinoids help with depression, but the SMH reports over 17,641 Australians were prescribed medicinal cannabis for depression through the federal government
- The Guardian notes the review did not find evidence for cannabis helping with opioid use disorder, but the SMH does not mention this condition in its coverage
- The Guardian highlights that the review did not distinguish between THC and CBD products, but the SMH explicitly mentions this as a limitation in the study
Source Articles
Cannabis is not an effective treatment for common mental health conditions, says review
International researchers find ‘very little evidence’ medical form of the drug can treat anxiety, anorexia and other disorders Cannabis is not an effective treatment for common mental health condition...
The $300 a week medicine Daniel feels better without
Daniel Yacoel is one of hundreds of thousands of Australians prescribed medicinal cannabis for a mental health condition but there is little evidence it works....